What is Legal Insider Trading? How do I use this site?
Learn More ›
Login/Signup
Top Companies
Form Screener
Random Insider
Random Company
Sectors
FAQ
Feedback
Blog
Pricing
Royalty Pharma plc (RPRX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
Date
Insider
Company
Owned Shares
Shares Traded
Price
Net Total
BUY
24 May 2023
Legorreta Pablo G.
CEO, Chairman of the Board, Director, Officer, 10% Owner
Royalty Pharma plc
(RPRX)
380,000
+65%
150,000
$32.25
$4,837,440.00
SELL
22 May 2023
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
6,762
-99%
1,750,000
$32.82
$57,435,000.00
BUY
16 May 2023
Legorreta Pablo G.
CEO, Chairman of the Board, Director, Officer, 10% Owner
Royalty Pharma plc
(RPRX)
230,000
+100%
230,000
$33.38
$7,676,823.50
SELL
29 Mar 2023
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
1,456,762
-8%
139,950
$36.31
$5,081,110.50
SELL
28 Mar 2023
Lloyd George W.
EVP, Investments & CLO, Officer
Royalty Pharma plc
(RPRX)
212,221
-34%
112,779
$37.06
$4,179,295.20
SELL
23 Feb 2023
Lloyd George W.
EVP, Investments & CLO, Officer
Royalty Pharma plc
(RPRX)
325,000
-7%
25,000
$37.27
$931,657.50
SELL
22 Feb 2023
Urist Marshall
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
46,667
-33%
23,333
$37.30
$870,239.25
SELL
9 Dec 2022
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
136,722
-30%
60,000
$42.01
$2,520,623.20
SELL
5 Dec 2022
Giuliani Mario Germano
Director, 10% Owner
Royalty Pharma plc
(RPRX)
7,795,072
-1%
84,302
$43.15
$3,637,462.50
SELL
1 Dec 2022
Giuliani Mario Germano
Director, 10% Owner
Royalty Pharma plc
(RPRX)
7,879,374
-4%
362,766
$44.04
$15,974,737.00
SELL
21 Nov 2022
Lloyd George W.
EVP, Investments & CLO, Officer
Royalty Pharma plc
(RPRX)
130,000
-23%
40,000
$43.14
$1,725,566.60
SELL
17 Nov 2022
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
156,712
-43%
120,000
$42.33
$5,079,924.00
SELL
10 Nov 2022
Lloyd George W.
EVP, Investments & CLO, Officer
Royalty Pharma plc
(RPRX)
165,000
-23%
50,000
$43.85
$2,192,612.50
SELL
8 Nov 2022
Coyne Terrance P.
EVP & CFO, Officer
Royalty Pharma plc
(RPRX)
940,000
-2%
24,500
$43.47
$1,065,012.50
SELL
2 Nov 2022
Coyne Terrance P.
EVP & CFO, Officer
Royalty Pharma plc
(RPRX)
964,500
-0%
5,500
$43.06
$236,845.95
SELL
28 Sep 2022
Giuliani Mario Germano
Director, 10% Owner
Royalty Pharma plc
(RPRX)
8,077,140
-0%
32,593
$41.05
$1,337,942.60
SELL
22 Sep 2022
Giuliani Mario Germano
Director, 10% Owner
Royalty Pharma plc
(RPRX)
8,109,733
-2%
211,380
$41.17
$8,702,113.00
SELL
20 Sep 2022
Giuliani Mario Germano
Director, 10% Owner
Royalty Pharma plc
(RPRX)
8,321,113
-5%
523,842
$41.07
$21,516,552.00
SELL
20 Sep 2022
GG 1978 SICAF SIF S.A. - GG Strategic
10% Owner
Royalty Pharma plc
(RPRX)
21,426,170
-1%
267,815
$41.02
$10,985,798.00
SELL
16 Sep 2022
Giuliani Mario Germano
Director, 10% Owner
Royalty Pharma plc
(RPRX)
22,657,816
-1%
387,171
$41.59
$16,101,818.00
SELL
16 Sep 2022
GG 1978 SICAF SIF S.A. - GG Strategic
10% Owner
Royalty Pharma plc
(RPRX)
21,693,984
-1%
387,171
$41.59
$16,101,933.00
SELL
14 Sep 2022
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
276,712
-26%
100,000
$42.30
$4,230,387.50
SELL
14 Sep 2022
Giuliani Mario Germano
Director, 10% Owner
Royalty Pharma plc
(RPRX)
23,044,986
-1%
345,014
$42.38
$14,622,926.00
SELL
14 Sep 2022
GG 1978 SICAF SIF S.A.
10% Owner
Royalty Pharma plc
(RPRX)
22,081,156
-1%
345,014
$42.38
$14,623,052.00
SELL
7 Sep 2022
Giuliani Mario Germano
Director, 10% Owner
Royalty Pharma plc
(RPRX)
8,577,140
-5%
499,500
$42.70
$21,327,336.00
SELL
7 Sep 2022
GG 1978 SICAF SIF S.A. - GG Strategic
10% Owner
Royalty Pharma plc
(RPRX)
22,426,170
-2%
498,006
$42.70
$21,262,532.00
SELL
25 Aug 2022
GG 1978 SICAF SIF S.A. - GG Strategic
10% Owner
Royalty Pharma plc
(RPRX)
22,924,176
-0%
1,994
$44.00
$87,736.00
SELL
25 Aug 2022
Giuliani Mario Germano
Director, 10% Owner
Royalty Pharma plc
(RPRX)
9,076,640
-0%
500
$44.00
$22,000.00
SELL
9 Aug 2022
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
376,712
-10%
45,000
$43.73
$1,967,823.00
SELL
9 Aug 2022
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
201,114
-9%
20,854
$43.92
$915,909.10
SELL
1 Aug 2022
Coyne Terrance P.
EVP & CFO, Officer
Royalty Pharma plc
(RPRX)
970,000
-3%
30,000
$43.19
$1,295,727.00
SELL
25 Jul 2022
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
380,000
-16%
75,100
$43.25
$3,248,199.20
SELL
25 Jul 2022
Urist Marshall
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
0
-100%
23,334
$43.18
$1,007,446.50
SELL
29 Jun 2022
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
421,712
-6%
30,000
$42.17
$1,265,238.00
SELL
24 Jun 2022
Urist Marshall
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
23,334
-49%
23,333
$43.19
$1,007,693.94
SELL
8 Jun 2022
Reddoch James F.
EVP & Chief Scientific Officer, Officer
Royalty Pharma plc
(RPRX)
920,800
-9%
100,000
$41.56
$4,155,899.80
SELL
27 May 2022
Reddoch James F.
EVP & Chief Scientific Officer, Officer
Royalty Pharma plc
(RPRX)
1,020,800
-6%
75,000
$41.08
$3,081,007.50
SELL
26 May 2022
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
430,000
-18%
100,000
$40.29
$4,029,091.20
SELL
23 May 2022
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
530,000
-15%
100,000
$40.27
$4,026,770.00
SELL
19 May 2022
Reddoch James F.
EVP & Chief Scientific Officer, Officer
Royalty Pharma plc
(RPRX)
1,095,800
-6%
75,000
$40.44
$3,033,127.50
SELL
19 May 2022
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
451,712
-24%
150,000
$39.42
$5,913,306.00
SELL
16 May 2022
Urist Marshall
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
46,667
-33%
23,333
$39.85
$929,836.40
SELL
29 Mar 2022
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
601,712
-9%
60,000
$38.59
$2,315,322.00
SELL
17 Mar 2022
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
0
-100%
169,089
$39.43
$6,667,520.50
BUY
24 Feb 2022
Fernandez Henry A
Director
Royalty Pharma plc
(RPRX)
58,200
+126%
32,500
$37.49
$1,218,373.00
SELL
28 Dec 2021
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
592,748
-23%
184,448
$40.12
$7,400,767.50
SELL
16 Nov 2021
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
630,000
-28%
250,000
$42.39
$10,596,693.00
SELL
16 Nov 2021
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
622,398
-25%
214,389
$42.34
$9,076,492.00
SELL
28 Sep 2021
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
615,112
-17%
128,425
$36.51
$4,688,288.00
SELL
26 Jul 2021
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
595,860
-2%
13,362
$39.78
$531,532.50
SELL
26 Jul 2021
Reddoch James F.
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
1,170,800
-0%
8,949
$39.78
$355,976.90
SELL
26 Jul 2021
Reddoch James F.
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
1,170,800
-0%
8,949
$39.78
$355,976.90
SELL
12 Jul 2021
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
600,773
-3%
23,149
$42.01
$972,455.94
SELL
12 Jul 2021
Reddoch James F.
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
1,179,749
-1%
17,934
$42.01
$753,369.30
SELL
6 Jul 2021
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
605,841
-12%
88,489
$42.19
$3,733,761.50
SELL
6 Jul 2021
Reddoch James F.
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
1,197,683
-5%
73,117
$42.19
$3,085,027.00
SELL
25 Jun 2021
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
3,931,058
-25%
1,314,912
$42.11
$55,370,132.00
SELL
10 Jun 2021
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
620,860
-10%
70,000
$46.49
$3,254,369.00
BUY
7 Jun 2021
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
2,081,540
+15%
273,650
$45.26
$12,385,399.00
SELL
4 Jun 2021
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
640,860
-28%
252,500
$46.01
$11,616,797.00
SELL
4 Jun 2021
Urist Marshall
EVP & Co-Head of R&I, Officer
Royalty Pharma plc
(RPRX)
0
-100%
33,134
$46.08
$1,526,720.50
SELL
4 Jun 2021
Reddoch James F.
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
1,270,800
-13%
200,000
$45.55
$9,110,690.00
SELL
2 Jun 2021
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
713,360
-8%
62,500
$42.12
$2,632,512.50
SELL
2 Jun 2021
Urist Marshall
EVP & Co-Head Research & Inv., Officer
Royalty Pharma plc
(RPRX)
33,134
-30%
14,566
$41.52
$604,850.25
SELL
2 Jun 2021
Reddoch James F.
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
1,470,800
-3%
50,000
$42.13
$2,106,560.00
SELL
20 May 2021
Urist Marshall
EVP & Co-Head Research & Inv., Officer
Royalty Pharma plc
(RPRX)
47,700
-4%
2,000
$41.08
$82,159.02
SELL
14 Apr 2021
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
50,000
-58%
69,822
$42.13
$2,941,920.00
SELL
14 Apr 2021
Reddoch James F.
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
200,000
-21%
55,714
$42.10
$2,345,593.00
SELL
12 Apr 2021
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
63,924
-0%
449
$42.32
$19,001.68
SELL
12 Apr 2021
Reddoch James F.
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
255,714
-0%
359
$42.32
$15,192.88
SELL
22 Mar 2021
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
64,013
-46%
54,729
$46.32
$2,535,226.20
SELL
22 Mar 2021
Reddoch James F.
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
256,073
-14%
43,927
$46.32
$2,034,518.50
SELL
3 Mar 2021
Coyne Terrance P.
EVP & CFO, Officer
Royalty Pharma plc
(RPRX)
270,180
-27%
100,000
$44.78
$4,478,450.50
SELL
2 Mar 2021
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
77,625
-61%
125,000
$46.94
$5,867,148.50
SELL
2 Mar 2021
Reddoch James F.
EVP, Research & Investments, Officer
Royalty Pharma plc
(RPRX)
303,510
-24%
100,000
$46.92
$4,692,158.00
SELL
2 Mar 2021
Coyne Terrance P.
EVP & CFO, Officer
Royalty Pharma plc
(RPRX)
305,022
-24%
100,000
$46.94
$4,694,090.00
BUY
25 Feb 2021
Fernandez Henry A
Director
Royalty Pharma plc
(RPRX)
25,700
+100%
25,700
$46.83
$1,203,479.60
SELL
17 Dec 2020
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% Owner
Royalty Pharma plc
(RPRX)
38,714,280
-15%
7,301,050
$43.92
$320,672,220.00
SELL
20 Oct 2020
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
0
-100%
463,200
$42.00
$19,454,400.00
BUY
18 Jun 2020
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% Owner
Royalty Pharma plc
(RPRX)
46,015,330
+6%
3,000,000
$28.00
$84,000,000.00
BUY
15 Jun 2020
Giuliani Mario Germano
Director, 10% Owner
Royalty Pharma plc
(RPRX)
50,000
+100%
50,000
$28.00
$1,400,000.00
BUY
15 Jun 2020
Lloyd George W.
EVP, Investments & GC, Officer
Royalty Pharma plc
(RPRX)
3,000
+126%
14,200
$28.00
$397,600.00
BUY
15 Jun 2020
Hite Christopher
EVP & Vice Chairman, Officer
Royalty Pharma plc
(RPRX)
70,000
+100%
70,000
$28.00
$1,960,000.00
BUY
15 Jun 2020
Legorreta Pablo G.
CEO, Chairman of the Board, Director, Officer, 10% Owner
Royalty Pharma plc
(RPRX)
10,000
+200%
20,000
$28.00
$560,000.00
BUY
15 Jun 2020
Coyne Terrance P.
EVP & CFO, Officer
Royalty Pharma plc
(RPRX)
1,500
+203%
2,950
$28.00
$82,600.00
BUY
15 Jun 2020
FORD WILLIAM E
Director
Royalty Pharma plc
(RPRX)
1,500,000
+100%
1,500,000
$28.00
$42,000,000.00
BUY
15 Jun 2020
RIGGS RORY B
Director
Royalty Pharma plc
(RPRX)
15,000
+100%
15,000
$28.00
$420,000.00
Home